Active substance
Piroxicam
- SFDA 17
- US FDA 23
- Health Canada 4
- US price lines 2
- NHS prices 5
- Safety 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| DISPERCAM 20MG-ML AMP.FOR I-M USE | 20 mg/ml | Solution for injection · Intramuscular use | 3 Ampoule | SAR 2.65 | Generic · Prescription | MEDICAL UNION PHARMACEUTICALS CO | Valid |
| DISPERCAM GEL 0.5% | 0.5 % | Gel · Topical | 1 Tube | SAR 2.80 | Generic · OTC | MEDICAL UNION PHARMACEUTICALS CO | Valid |
| FELDENE 20MG DISPERSABLE TAB | 20 mg | Dispersible tablet · Oral use | 10 Blister | SAR 22.50 | NCE · Prescription | SPIMACO ADDWAEIH | Valid |
| FELDENE 20MG-ML AMP. | 20 mg/ml | Solution for injection · Intramuscular use | 5 Ampoule | SAR 29.20 | NCE · Prescription | SPIMACO ADDWAEIH | Valid |
| BREXIN 20MG TABLETS | 20 mg | Tablet · Oral use | 10 Blister | SAR 8.65 | Generic · Prescription | CHIESI FARMACEUTICIS | Withdrawn by MAH · Not Marketed |
| FELDENE 10MG CAPS | 10 mg | Capsule · Oral use | 20 Blister | SAR 26.00 | Generic · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| FELDENE 10MG DISPERSABLE TAB | 10 mg | Dispersible tablet · Oral use | 20 Blister | SAR 22.50 | NCE · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| FELDENE 20MG CAPS | 20 mg | Capsule · Oral use | 10 Blister | SAR 22.65 | Generic · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| FELDENE 20MG SUPPOSITORY | 20 mg | Suppository · Rectal use | 20 Blister | SAR 22.55 | NCE · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
| FELDENE GEL 0.5% | 0.5 % | Gel · Topical | 1 Tube | SAR 13.35 | NCE · OTC | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| NOVO-PIROCAM 10MG CAPS | 10 mg | Capsule · Oral use | 20 Blister | SAR 20.75 | NCE · Prescription | NOVOPHARM | Withdrawn by MAH · Not Marketed |
| ORTHOCAM 0.5% GEL | 0.5 % | Gel · Topical | 1 Tube | SAR 10.65 | Generic · OTC | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
| ORTHOCAM 10 CAPS | 10 mg | Capsule · Oral use | 20 Blister | SAR 21.60 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
| ORTHOCAM 20 CAPS | 20 mg | Capsule · Oral use | 10 Blister | SAR 18.85 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
| ORTHOCAM DT 10MG | 10 mg | Dispersible tablet · Oral use | 20 Blister | SAR 18.95 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
| ORTHOCAM DT 20MG | 20 mg | Dispersible tablet · Oral use | 10 Blister | SAR 18.95 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
| SHIFA PIROXICAM 20 MG-ML I.M AMP | 20 mg/ml | Injection · Intramuscular use | 5 Ampoule | SAR 3.85 | NCE · Prescription | SHIFA PHARMACEUTICAL INDUSTRIES | Invalid · Not Marketed |
Indications — CHI Daman Drug Formulary
ACUTE PANCREATITIS-PAIN MANAGEMENT; ENDOMETRIOSIS; LOW BACK PAIN; PAIN MANAGEMENT IN CANCER PATIENTS; POSTOPERATIVE PAIN; RENAL AND URETERIC STONES; RHEUMATOID ARITHRITIS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| FELDENE | 10MG; 20MG | capsule · oral | PFIZER | Prescription | 6 Apr 1982 |
| PIROXICAM | 10MG; 20MG | capsule · oral | TEVA | Prescription | 11 Dec 1992 |
| PIROXICAM | 20MG; 10MG | capsule · oral | SOLIS PHARMS | Prescription | 15 Jun 1993 |
| PIROXICAM | 10MG; 20MG | capsule · oral | MICRO LABS | Prescription | 29 Dec 2017 |
| PIROXICAM | 10MG; 20MG | capsule · oral | STRIDES PHARMA | Prescription | 26 Jan 2018 |
| PIROXICAM | 10MG; 20MG | capsule · oral | ZYDUS LIFESCIENCES | Prescription | 17 Jul 2018 |
| PIROXICAM | 10MG; 20MG | capsule · oral | SCS | Discontinued | 29 May 1992 |
| PIROXICAM | 10MG; 20MG | capsule · oral | PHARMOBEDIENT | Discontinued | 31 Jul 1992 |
| PIROXICAM | 10MG; 20MG | capsule · oral | TEVA PHARMS | Discontinued | 28 Aug 1992 |
| PIROXICAM | 10MG; 20MG | capsule · oral | MYLAN | Discontinued | 22 Sep 1992 |
| PIROXICAM | 20MG; 10MG | capsule · oral | SUN PHARM INDUSTRIES | Discontinued | 12 Mar 1993 |
| PIROXICAM | 10MG | capsule · oral | TEVA | Discontinued | 28 Jan 1994 |
| PIROXICAM | 20MG | capsule · oral | TEVA | Discontinued | 28 Jan 1994 |
| PIROXICAM | 10MG; 20MG | capsule · oral | WATSON LABS | Discontinued | 29 Sep 1995 |
| PIROXICAM | 10MG; 20MG | capsule · oral | WATSON LABS | Discontinued | 16 May 1996 |
| PIROXICAM | 10MG; 20MG | capsule · oral | IVAX SUB TEVA PHARMS | Discontinued | 3 Jun 1996 |
| PIROXICAM | 10MG; 20MG | capsule · oral | EGIS | Discontinued | 8 Jul 1997 |
| PIROXICAM | 10MG; 20MG | capsule · oral | FLAMINGO PHARMS | Discontinued | 9 Sep 2016 |
| PIROXICAM | 10MG; 20MG | capsule · oral | UNICHEM | Discontinued | 13 Apr 2017 |
| PIROXICAM | 10MG; 20MG | capsule · oral | STRIDES PHARMA | Discontinued | 20 Jun 2017 |
| PIROXICAM | 10MG; 20MG | capsule · oral | HIKMA | Discontinued | 11 Aug 2017 |
| PIROXICAM | 10MG; 20MG | capsule · oral | BRECKENRIDGE | Discontinued | 21 Feb 2018 |
| PIROXICAM | 10MG; 20MG | capsule · oral | CYCLE | Discontinued |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO PIROXICAM CAP 10MG | 00642886 | 10 MG | CAPSULE · ORAL | APOTEX INC |
| APO PIROXICAM CAP 20MG | 00642894 | 20 MG | CAPSULE · ORAL | APOTEX INC |
| TEVA-PIROXICAM | 00695696 | 20 MG | CAPSULE · ORAL | TEVA CANADA LIMITED |
| TEVA-PIROXICAM | 00695718 | 10 MG | CAPSULE · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | PIROXICAM 10 MG CAPSULE | $0.15768 | per EA | 23 Sep 2026 |
| US NADAC | PIROXICAM 20 MG CAPSULE | $0.21465 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Piroxicam 0.5% gel | £1.49 | 60 gram | 1 Oct 2026 |
| NHS Drug Tariff | Piroxicam 0.5% gel | £2.78 | 112 gram | 1 Oct 2026 |
| NHS Drug Tariff | Piroxicam 10mg capsules | £16.00 | 56 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Piroxicam 20mg capsules | £24.00 | 28 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Piroxicam 20mg orodispersible tablets sugar free | £10.53 | 30 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 21 Nov 2024 FELDENE — safety-related labeling change
Labeling sections changed: Boxed Warning; Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - MHRA 11 Dec 2014 Piroxicam: new restrictions, including specialist initiation
Systemic piroxicam should be initiated only by specialists as a second-line treatment for arthritis, with patients who currently take piroxicam reassessed at a routine appointment.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.